Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction between phenytoin and valproate.

L N Sansom, R C Beran, G J Schapel

    The Medical Journal of Australia
    |August 23, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hospitalization rates as outcome indicators of national medicinal drug policies: the example of gastrointestinal ulcer.

    Pharmacoepidemiology and drug safety·2004
    Same author

    Surfing, self-medicating and safety: buying non-prescription and complementary medicines via the internet.

    Quality & safety in health care·2003
    Same author

    'Pharmacist only' medicines.

    Australian and New Zealand journal of public health·2000
    Same author

    Drug-related hospital admissions: a review of Australian studies published 1988-1996.

    The Medical journal of Australia·1998
    Same author

    A survey of lamotrigine and vigabatrin treatment in children with severe epilepsy.

    Seizure·1998
    Same author

    The effects of cyclophosphamide on the pharmacokinetics of triiodothyronine in the male rat.

    The Journal of pharmacy and pharmacology·1996
    Same journal

    Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population.

    The Medical journal of Australia·2026
    Same journal

    Striving for Racial Equity in Oral Cancer Research: A Case Study.

    The Medical journal of Australia·2026
    Same journal

    Progressing Cross-Sector Collaboration for People With Eating Disorders and Higher Weight: Priority Actions From an Expert Roundtable Using a Modified Nominal Group Technique.

    The Medical journal of Australia·2026
    Same journal

    Self-Poisoning With Prazosin and Its Off-Label Use in Australia, 2014-2024: Analysis of NSW Poisons Information Centre Data.

    The Medical journal of Australia·2026
    Same journal

    Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective.

    The Medical journal of Australia·2026
    Same journal

    Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments.

    The Medical journal of Australia·2026
    See all related articles

    Valproate displaces phenytoin from plasma proteins, lowering total serum phenytoin levels. However, no phenytoin dosage adjustment is needed because free phenytoin levels remain stable.

    Area of Science:

    • Pharmacology
    • Clinical Pharmacy

    Background:

    • Phenytoin is an anticonvulsant medication with a narrow therapeutic index.
    • Valproate is another antiepileptic drug known to interact with other medications.
    • Drug interactions can affect patient outcomes and require careful management.

    Purpose of the Study:

    • To investigate the effect of valproate on phenytoin protein binding and serum levels.
    • To determine the clinical implications of this drug interaction on phenytoin dosing.

    Main Methods:

    • The study likely involved analyzing serum samples from patients taking both phenytoin and valproate.
    • Measurement of total and free phenytoin concentrations.
    • Assessment of protein binding displacement.

    Related Experiment Videos

    Main Results:

    • Valproate significantly displaced phenytoin from plasma protein binding sites.
    • This displacement led to a decrease in total serum phenytoin concentrations.
    • Crucially, free (unbound) phenytoin levels remained unaffected.

    Conclusions:

    • The interaction between valproate and phenytoin results in reduced total phenytoin levels due to protein displacement.
    • No dose adjustment for phenytoin is necessary solely based on decreased total levels.
    • Clinical monitoring for phenytoin toxicity or subtherapeutic effects is still important.